文献速递神经肿瘤

ELF4是miRNA-转录因子网络的关键组分,也是胶质母细胞瘤受体信号与脂质动态的桥接调控因子

ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics.
PubMed 文献 · Neuro Oncol · 2023-01-01

该研究通过高通量功能性siRNA筛选在胶质母细胞瘤细胞中鉴定出E74样ETS转录因子4(ELF4)是驱动致癌表型的主要贡献者,体外和体内实验显示ELF4敲低导致增殖延迟和凋亡,机制上ELF4控制受体酪氨酸激酶信号和脂质动态两条相互关联的通路。

要点

  • 高通量siRNA筛选鉴定ELF4为胶质母细胞瘤致癌表型的主要贡献因子。
  • ELF4敲低导致GBM细胞显著增殖延迟和凋亡,以及胶质瘤干细胞长期生长延迟和形态改变。
  • ELF4调控RTK信号(SRC、PTK2B、TNK2)和脂质动态(LRP1、APOE、ABCA7、PLA2G6、PITPNM2)两条通路。

核心结论

  • ELF4通过控制RTK信号(SRC、PTK2B、TNK2)和脂质动态(LRP1、APOE、ABCA7、PLA2G6、PITPNM2)两条依赖通路的基因,对GBM细胞身份至关重要。
  • 数据提示同时靶向这两条通路可能对GBM患者具有治疗益处。

研究设计与样本

  • 在胶质母细胞瘤细胞中进行高通量功能性siRNA筛选,鉴定ELF4为致癌表型的主要贡献者。
  • 采用体外和体内实验评估ELF4对癌症表型的影响。
  • 通过基因组和脂质组分析表征ELF4的作用机制,并用MAPK报告基因实验验证ELF4对MAPK信号的影响,用qRT-PCR和western blotting证实ELF4对最相关靶基因的调控作用。

主要发现

  • ELF4敲低导致GBM细胞显著增殖延迟和凋亡,以及胶质瘤干细胞(GSCs)长期生长延迟和形态改变。
  • 转录组分析显示ELF4控制两条相互关联的通路:受体酪氨酸激酶信号和脂质动态。
  • ELF4调控直接影响RTK信号,因为MAPK活性依赖于ELF4水平。
  • 鸟枪脂质组学显示ELF4耗竭破坏了若干磷脂类别,突显ELF4在脂质稳态中的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The loss of neurogenic tumor suppressor microRNAs miR-124, miR-128, and miR-137 is associated with glioblastoma's undifferentiated state. Most of their impact comes via the repression of a network of oncogenic transcription factors. We conducted a high-throughput functional siRNA screen in glioblastoma cells and identify E74 like ETS transcription factor 4 (ELF4) as the leading contributor to oncogenic phenotypes. METHODS: In vitro and in vivo assays were used to assess ELF4 impact on cancer phenotypes. We characterized ELF4's mechanism of action via genomic and lipidomic analyses. A MAPK reporter assay verified ELF4's impact on MAPK signaling, and qRT-PCR and western blotting were used to corroborate ELF4 regulatory role on most relevant target genes. RESULTS: ELF4 knockdown resulted in significant proliferation delay and apoptosis in GBM cells and long-term growth delay and morphological changes in glioma stem cells (GSCs). Transcriptomic analyses revealed that ELF4 controls two interlinked pathways: 1) Receptor tyrosine kinase signaling and 2) Lipid dynamics. ELF4 modulation directly affected receptor tyrosine kinase (RTK) signaling, as mitogen-activated protein kinase (MAPK) activity was dependent upon ELF4 levels. Furthermore, shotgun lipidomics revealed that ELF4 depletion disrupted several phospholipid classes, highlighting ELF4's importance in lipid homeostasis. CONCLUSIONS: We found that ELF4 is critical for the GBM cell identity by controlling genes of two dependent pathways: RTK signaling (SRC, PTK2B, and TNK2) and lipid dynamics (LRP1, APOE, ABCA7, PLA2G6, and PITPNM2). Our data suggest that targeting these two pathways simultaneously may be therapeutically beneficial to GBM patients.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Kosti A, Chiou J, Guardia GDA, et al. ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics. Neuro Oncol. 2023. PMID: 35862252. doi:10.1093/neuonc/noac179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。